Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn’s disease-type necrotizing colitis in Mice
© Momotani et al.; licensee Springer. 2012
Received: 12 September 2012
Accepted: 29 October 2012
Published: 8 November 2012
Background: A 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced murine colitis model was developed to investigate the pathogenesis and to evaluate a method of treating human Crohn’s disease. This experimental model rapidly induces colitis similar to human Crohn’s disease lesion in a reproducible manner. However, natural exposure of the human digestive tract to TNBS is unrealistic. A novel animal model based on realistic data is eagerly anticipated in future research on pathogenesis of CD. Method: We evaluated the potency of Map antigen molecules in an effort to develop a novel colitis model using a more realistic source than TNBS. We prepared the Map antigen by ethanol extraction and developed a mouse model in a manner similar to that of the well-known TNBS-induced colitis in mice. In the experiment, seven days after subcutaneous (SC) injection of the antigen into normal C57BL/6 mice, the same antigen in 50% ethanol was injected into the colon by the transanal route with a fine cannula. Results: On the fifth day after the transanal injection, histopathological examination revealed full-thickness necrotizing colitis with erosion and ulcers; severe infiltration with neutrophils, lymphocytes, macrophages, and perforation. However, no change was detected with each single Map-antigen injection. Conclusion: The present results provide a novel animal model for research on CD and may be the key to clarifying the relationship between CD and Map. This is the first evidence that mycobacterium antigen induces necrotizing colitis.
KeywordsMycobacterium Paratuberculosis Crohn’s disease IBD Mice Necrotizing colitis TNBS
The number of studies attempting to detect clues to the mystery of Crohn’s disease (CD), a chronic intractable intestinal disease, has recently increased (Lakatos 2009; Momotani et al. 2012; Simmons 2010). Althoug various symptomatic treatments and approaches to diet restriction half of CD patients require surgery within 10 years after diagnosis. The risk of postoperative recurrence is 44 to 55% after 10 years (Peyrin-Biroulet et al. 2010). The globally rising rate of pediatric CD is also a major issue (Benchimol et al. 2011; Jakobsen et al. 2008; Phavichitr et al. 2003). No convincing explanation of the pathogenesis of CD currently exists; however, various environmental factors (e.g., pathogenic or non-pathogenic microbes, lifestyle, hygiene factors, diet, and stress) have been suggested (Economou and Pappas 2008; Glasser and Darfeuille-Michaud 2008; Lakatos 2009; Momotani et al. 2012; Neuman and Nanau 2012). Responsible host genes such as the famous NOD2 and a genetic predisposition to CD have been suspected as well (Economou and Pappas 2008; Glasser and Darfeuille-Michaud 2008; Umeno et al. 2011; Vora et al. 2012). The focus in recent years has been on Mycobacterium avium subsp. paratuberculosis (Map) (Behr and Kapur 2008; Eltholth et al. 2009; Momotani et al. 2012), due to the reported pathological similarities of CD and paratuberculosis (Ptb), accumulating reports of frequent detection of Map IS900 DNA, and much less isolation of Map from CD lesions (Abubakar et al. 2008; Chiodini 1989; Feller et al. 2007; Momotani et al. 2012). Detection of live Map and Map IS900 DNA in children with early-onset CD has been reported (Kirkwood et al. 2009).
Paratuberculosis is a chronic and progressive granulomatous enteritis that affects livestock and wild animals worldwide (Chiodini et al. 1984; Momotani et al. 2012; Nielsen and Toft 2009; Raizman et al. 2009; Stabel et al. 2009). However, differences between CD and Ptb have been pointed out (Momotani et al. 2012; Van Kruiningen 1999). An additional mystery is the “invisible Map” that supposedly grows in CD lesions (Momotani et al. 2012; Pierce 2009; Van Kruiningen 1999). This phenomenon has been explained by isolation of a cell-wall-deficient, spheroplastic form of Map from human CD lesions (Wall et al. 1993). However, even immunohistochemical staining for cytoplasmic and cell-wall components of Map could not detect Map in CD lesions (Kobayashi et al. 1989; Momotani et al. 2012; Pierce 2009; Sartor 2005; Van Kruiningen 1999). In contrast to the hypothesis that Map infection causes CD, there are no reports of CD-like Ptb lesions in natural or experimental infection with Map (Chiodini 1989; Chiodini et al. 1984). Furthermore, intestinal lesions in Ptb of cynomolgus were very similar to those of bovine but differed histopathologically from human CD (McClure et al. 1987).
An experimental colitis model using mice or rats with haptenizing agent 2,4,6-trinitrobenzene sulfonic acid (TNBS) yields pathological findings similar to those of human CD (Arita et al. 2005; Neurath et al. 2000; te Velde et al. 2006). However, natural exposure of the human digestive tract to TNBS is unrealistic. In contrast, exposure of the human digestive tract to Map antigen is realistic (Behr and Kapur 2008; Eltholth et al. 2009; Over et al. 2011), since frequently detected Map IS900 DNA in CD patients (Abubakar et al. 2008; Chiodini 1989; Feller et al. 2007; Momotani et al. 2012) is considered to be evidence of Map antigen exposure, rather than Map infection. In the present study, we prepared a lipophilic antigen of Map, and TNBS in the previous TNBS colitis model (Arita et al. 2005) was replaced with the Map antigen. Histopathological evaluation revealed severe necrotizing colitis that is very similar to that in the well-known TNBS colitis model. The present study proposes a new CD model and a novel hypothesis on the pathogenesis of human CD.
Clinical findings and gross pathology
Stacked bar graphs present histopathological findings regarding degree (Figure 1B), distribution of lesions (Figure 1B), and types of infiltrating cells (Figure 1C). All sections were stained with hematoxylin and eosin (H&E), and the magnification of photos is indicated as a bar.
Groups 5 and 6
The present study provides the first evidence that the Map antigen has the potency to induce colitis that is very similar to mouse TNBS-induced colitis, which has been used as an experimental Crohn’s disease model (Arita et al. 2005; Neurath et al. 2000; te Velde et al. 2006). The nature of the inflammation observed in the present study was very different from that of natural Ptb inflammation (Chiodini et al. 1984; Veazey et al. 1995), but rather similar to human Crohn’s disease enteritis (Loddenkemper 2009; Momotani et al. 2012). However, granuloma formation, a characteristic finding in CD (Loddenkemper 2009; Momotani et al. 2012), was not observed in Map-L and TNBS-induced acute phase colitis in the present study. This finding coincided with previous findings in the study of acute TNBS colitis (Arita et al. 2005; Neurath et al. 2000; te Velde et al. 2006; Wirtz et al. 2007). The necrotizing colitis consisted of erosion, ulceration, and infiltration with neutrophil, lymphocyte, and macrophage. Development of ulceration and regeneration by granulation tissue was also observed. The damaged tissues were restricted, and the adjacent area indicated normal or mild changes in the present TNBS- and Map-induced colitis. The finding that the changes may be somewhat similar to “skip lesions” is important in differentiating CD from UC (Wakefield et al. 1989). Every characteristic change in TNBS-induced colitis was observed in the present Map antigen-induced lesions. However, cellular infiltration in the muscular layer in Map antigen-induced colitis was more prominent than in TNBS-induced colitis (Arita et al. 2005; Neurath et al. 2000; te Velde et al. 2006). In human CD enteritis, severe cellular infiltration or lymphoid follicle formation in the muscular layer is very common (Baumgart and Sandborn 2007; Loddenkemper 2009; Momotani et al. 2012). This Map-induced colitis may be closer to human CD lesions than TNBS-induced colitis.
This is the first objective attempt to produce necrotizing colitis by mycobacterial antigen. The results suggest the novel etiological relationship of Map to human CD. Traditional etiological studies on CD and Map have been carried out under the hypothesis that “Map infection” causes CD (Behr and Kapur 2008; Gill et al. 2011; Hermon-Taylor et al. 2000). The effect of a “Map antigen” that can contaminate dairy products (Eltholth et al. 2009; Foods 2010; Hermon-Taylor et al. 2000; Millar et al. 1996; Patel and Shah 2011) and meat (Alonso-Hearn et al. 2009; Gill et al. 2011; Klanicova et al. 2011) from Ptb-infected cattle on human health was not reflected as an etiology of CD (Economou and Pappas 2008; Glasser and Darfeuille-Michaud 2008; Lakatos 2009; Umeno et al. 2011). As many previous studies have indicated, the detection of Map-specific DNA IS900 by PCR from human intestine, blood, and feces (Abubakar et al. 2008; Chiodini 1989; Tuci et al. 2011) or by in situ hybridization in intestines (Romero et al. 2005) may be evidence of exposure to the Map antigen complex but does not always mean the presence of live Map. The present results may solve the problem of meeting a requirement of Koch's postulates in analyzing the relationship between CD and Map (Lowe et al. 2008).
The facts that colitis in the present study occurred only with repeated exposure to the Map antigen and that similar histopathological characteristics were observed after a second exposure to the Map antigen in different concentrations suggest the contribution of an immunological mechanism, presumably a delayed-type hypersensitivity (DTH) reaction (Black 1999; Kobayashi et al. 2001). Similar pathogenesis has been considered in TNBS colitis (te Velde et al. 2006). However, further molecular pathological studies are necessary. Recent reports on Map- specific reactive CD4 T cells in CD patients (Olsen et al. 2009) suggest the contribution of a DTH reaction generated in the intestine by the Map antigen in the pathogenesis of CD. In addition, recent studies on the importance of CD1-presented mycobacterial lipid antigens in the host immune system (Watanabe et al. 2006) provide direction for future research on the pathogenesis of CD.
Epidemiological studies also suggest that the western diet is related to the incidence of CD (Lakatos 2006). The probability that people having some genetic predisposition will ingest live Map in food is minimal, but the chance of exposure by heat-killed Map antigen may be very frequent. Although the heating process of dairy products eliminates live Map (Stabel 2000; Stabel and Lambertz 2004; Stabel et al. 1997), it may not eliminate hazards to human health. Of course, we should not neglect the possibility of human Map infection (Hermon-Taylor 2009; Singh et al. 2010).
The present study proposed a novel mouse model for CD-like colitis and the ability of Map antigen to induce necrotizing colitis, which may be the key to understanding the relationship between CD and Map. This model may help clarify the pathogenesis of CD, as well as other diseases with a suspected etiological relationship to Map (e.g., irritable bowel syndrome (Scanu et al. 2007), multiple sclerosis (Cossu et al. 2011), and type-1 diabetes mellitus (Paccagnini et al. 2009)). Also, this is the first evidence that mycobacterium antigen induces necrotizing colitis. In addition, the authors recommend that people who may have a genetic predisposition (Economou and Pappas 2008; Economou et al. 2004; Glasser and Darfeuille-Michaud 2008; Henderson et al. 2011; Lakatos 2009; Tsianos et al. 2012; Tuci et al. 2011; Umeno et al. 2011) to CD (i.e., if a relative has CD) should avoid dairy products possibly contaminated with the Map antigen (Eltholth et al. 2009; Foods 2010; Hermon-Taylor et al. 2000; Millar et al. 1996; Patel and Shah 2011) because no other measures for preventing CD are known.
Mycobacterium avium subspecies paratuberculosis (ATCC 19698) was grown in Middle brook 7H9 liquid medium (Difco Laboratories, MD, USA) enriched with BBL Middle brook OADC (Becton Dickinson, Tokyo, Japan) and 2mg/L of mycobactin J (Allied Laboratory, MO, USA) for two weeks. Next, 90 ml of the culture was centrifuged at 2,200xg for 20min, the supernatant was removed, and the culture was re-suspended in phosphate buffer saline (PBS). After washing twice with PBS, wet bacilli (1g wet weight) were collected. Surface lipophilic antigen was isolated by a previous method (Speer et al. 2006). The bacilli were suspended in 12ml of 80% ethanol by vortex at room temperature for 1min. The suspension was centrifuged, and the resulting supernatant was collected. The dried material weighed 20mg; thus, the concentration was calculated as 1.7mg/ml in 80% ethanol. The material (Map-L antigen) was dissolved with 50% ethanol and used as MAP-L100 antigen (0.68μg/μl). Antigens serially diluted 10 times were used as MAP-L10 (0.068μg/μl) and MAP-L1 antigen (0.0068μg/μl). Preparation of the culture and isolation of the antigen were carried out in laboratory certified as a biosafety level 2 (BSL2-TS-49) in NIAH.
C57BL/6Cr Slc female mice at 10 weeks old were purchased from Japan SLC, Inc., and kept in a specific-pathogen-free (SPF) environment under the conditions described above. The mice were fed ad libitum during the experiments.
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Animal Health. The protocol was approved by the Committee of the Ethics of Animal Experiments of the NIAH (Permit Numbers: 08–118, 09–130 and A10-025), and all efforts were made to minimize suffering. All treatments were performed under general anesthesia with Avertin (2,2,-Tribromoethanol) (Arita et al. 2005). The mice were divided into six groups and injected twice with different antigens (Figure 1A). The primary injection was performed subcutaneously. The secondary antigen injections to the colon were performed through the trans-anal route with a fine urinary catheter (Atom Multipurpose Tube, 1.35mm in diameter, Atom Medical Corporation, Tokyo). Feeding was stopped 24 h before the secondary injection. This experimental procedure was basically accorded to previously reported TNBS colitis model by Arita et al. (Arita et al. 2005), because of the the favorable reproducibility.
Group 1 mice, TNBS positive control group were treated subcutaneously with 2.5% TNBS in 50% ethanol and then injected with 10% TNBS in ethanol by the transanal route. All mice in groups 2, 3, and 4 were subcutaneously injected with 25.5μg/150μl of MAP-L antigen in 50% ethanol (Map-L100 antigen). Seven days after treatment, the same antigen with three different concentrations (2.5 (MAP-L100), 0.25 (MAP-L10), and 0.025μg (MAP-L1)/150μl in 50% ethanol) were injected into the colon. Group 5 mice were pretreated subcutaneously with 50% ethanol, and then 25μg of MAP-L100 antigen per 150μl in 50% ethanol was injected into the colon. Group 6 mice were treated with 50% ethanol by SC injection and then by injection into the colon as a non-antigen control. Five days after the injection, the mice were put down by carbon dioxide gas. Colon tissues were sampled and fixed in 20% buffered formalin solution for histopathological examination. The fixative was gently injected into the lumen of the intestine by syringe with a 21 gauge needle.
All experiment protocols used in this study were approved by the Ethics Review Committee for Animal Experimentation of NIAH (approval Nos. 08–118 and 09–130).
Tissues fixed for three days were trimmed to be round slices and embedded in paraffin blocks. Sections were cut 4μm thick and stained with hematoxylin and eosin (H&E) and then observed under a microscope. The findings were recorded, and the degree of changes were expressed as 0 to 3 and made stacked bar graphs. (Figures A1-3).
EM, HO, MH and MI conceived and designed the experiments. SE purified the antigen. EM, SE, SY and TK performed the experiments. EM, HO, MH, SE and MI analyzed the data. EM, HO, MH, and SE contributed reagents, materials, or analysis tools. EM, SE, SY and MI wrote the paper. All authors read and approved the final manuscript.
Mycobacterium avium subsp. paratuberculosis
2,4,6-trinitrobenzene sulfonic acid
Oleic Acid-Albumin Fraction V-Dextrose-Catalase enrichment
This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education No. 23240061(to EM) and No. 20228005 (to H O), and the Bio-oriented Technology Research Advancement Institute (BRAIN) (to EM). We thank Mr. M. Kobayashi and Ms. M. Shimada for preparing excellent histopathological sections.
- Abubakar I, Myhill D, Aliyu SH, Hunter PR: Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis 2008, 14: 401-410. 10.1002/ibd.20276View ArticleGoogle Scholar
- Alonso-Hearn M, Molina E, Geijo M, Vazquez P, Sevilla I, Garrido JM, Juste RA: Isolation of Mycobacterium avium subsp. paratuberculosis from muscle tissue of naturally infected cattle. Foodborne Pathog Dis 2009, 6: 513-518. 10.1089/fpd.2008.0226View ArticleGoogle Scholar
- Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN: Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 2005, 102: 7671-7676. 10.1073/pnas.0409271102View ArticleGoogle Scholar
- Baumgart DC, Sandborn WJ: Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369: 1641-1657. 10.1016/S0140-6736(07)60751-XView ArticleGoogle Scholar
- Behr MA, Kapur V: The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr Opin Gastroenterol 2008, 24: 17-21. 10.1097/MOG.0b013e3282f1dcc4View ArticleGoogle Scholar
- Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM: Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011, 17: 423-439. 10.1002/ibd.21349View ArticleGoogle Scholar
- Black CA: Delayed type hypersensitivity: current theories with an historic perspective. Dermatol Online J 1999, 5: 7.Google Scholar
- Chiodini RJ: Crohn's disease and the mycobacterioses: a review and comparison of two disease entities. Clin Microbio Rev 1989, 2: 90-117.Google Scholar
- Chiodini RJ, Van Kruiningen HJ, Merkal RS: Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Vet 1984, 74: 218-262.Google Scholar
- Cossu D, Cocco E, Paccagnini D, Masala S, Ahmed N, Frau J, Marrosu MG, Sechi LA: Association of Mycobacterium avium subsp. paratuberculosis with multiple sclerosis in Sardinian patients. PLoS One 2011, 6: e18482. 10.1371/journal.pone.0018482View ArticleGoogle Scholar
- Economou M, Pappas G: New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 2008, 14: 709-720. 10.1002/ibd.20352View ArticleGoogle Scholar
- Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP: Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a meta analysis. Am J Gastroenterol 2004, 99: 2393-2404. 10.1111/j.1572-0241.2004.40304.xView ArticleGoogle Scholar
- Eltholth MM, Marsh VR, Van Winden S, Guitian FJ: Contamination of food products with Mycobacterium avium paratuberculosis : a systematic review. J Appl Microbiol 2009, 107: 1061-1071. 10.1111/j.1365-2672.2009.04286.xView ArticleGoogle Scholar
- Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, Furrer H, Pfyffer GE, Jemmi T, Baumgartner A, Egger M: Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 2007, 7: 607-613. 10.1016/S1473-3099(07)70211-6View ArticleGoogle Scholar
- Foods NACoMCf: Assessment of food as a source of exposure to Mycobacterium avium subspecies paratuberculosis (MAP). J Food Prot 2010, 73: 1357-1397.Google Scholar
- Gill CO, Saucier L, Meadus WJ: Mycobacterium avium subsp. paratuberculosis in dairy products, meat, and drinking water. J Food Prot 2011, 74: 480-499. 10.4315/0362-028X.JFP-10-301View ArticleGoogle Scholar
- Glasser AL, Darfeuille-Michaud A: Abnormalities in the handling of intracellular bacteria in Crohn's disease: a link between infectious etiology and host genetic susceptibility. Arch Immunol Ther Exp (Warsz) 2008, 56: 237-244. 10.1007/s00005-008-0026-1View ArticleGoogle Scholar
- Henderson P, van Limbergen JE, Wilson DC, Satsangi J, Russell RK: Genetics of childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 2011, 17: 346-361. 10.1002/ibd.21283View ArticleGoogle Scholar
- Hermon-Taylor J: Mycobacterium avium subspecies paratuberculosis , Crohn's disease and the Doomsday scenario. Gut Pathog 2009, 1: 15. 10.1186/1757-4749-1-15View ArticleGoogle Scholar
- Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N: Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis . Can J Gastroenterol 2000, 14: 521-539.Google Scholar
- Jakobsen C, Wewer V, Urne F, Andersen J, Faerk J, Kramer I, Stagegaard B, Pilgaard B, Weile B, Paerregaard A: Incidence of ulcerative colitis and Crohn's disease in Danish children: still rising or levelling out? J Crohns Colitis 2008, 2: 152-157. 10.1016/j.crohns.2008.01.006View ArticleGoogle Scholar
- Kirkwood CD, Wagner J, Boniface K, Vaughan J, Michalski WP, Catto-Smith AG, Cameron DJ, Bishop RF: Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm Bowel Dis 2009, 15: 1643-1655. 10.1002/ibd.20967View ArticleGoogle Scholar
- Klanicova B, Slana I, Vondruskova H, Kaevska M, Pavlik I: Real-time quantitative PCR detection of Mycobacterium avium subspecies in meat products. J Food Prot 2011, 74: 636-640. 10.4315/0362-028X.JFP-10-332View ArticleGoogle Scholar
- Kobayashi K, Blaser MJ, Brown WR: Immunohistochemical examination for mycobacteria in intestinal tissues from patients with Crohn's disease. Gastroenterol 1989, 96: 1009-1015.Google Scholar
- Kobayashi K, Kaneda K, Kasama T: Immunopathogenesis of delayed-type hypersensitivity. Microsc Res Tech 2001, 53: 241-245. 10.1002/jemt.1090View ArticleGoogle Scholar
- Lakatos PL: Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006, 12: 6102-6108.Google Scholar
- Lakatos PL: Environmental factors affecting inflammatory bowel disease: have we made progress? Dig Dis 2009, 27: 215-225. 10.1159/000228553View ArticleGoogle Scholar
- Loddenkemper C: Diagnostic standards in the pathology of inflammatory bowel disease. Dig Dis 2009, 27: 576-583. 10.1159/000233301View ArticleGoogle Scholar
- Lowe AM, Yansouni CP, Behr MA: Causality and gastrointestinal infections: Koch, Hill, and Crohn's. Lancet Infect Dis 2008, 8: 720-726. 10.1016/S1473-3099(08)70257-3View ArticleGoogle Scholar
- McClure HM, Chiodini RJ, Anderson DC, Swenson RB, Thayer WR, Coutu JA: Mycobacterium paratuberculosis infection in a colony of stumptail macaques (Macaca arctoides). J Infect Dis 1987, 155: 1011-1019. 10.1093/infdis/155.5.1011View ArticleGoogle Scholar
- Millar D, Ford J, Sanderson J, Withey S, Tizard M, Doran T, Hermon-Taylor J: IS900 PCR to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cows' milk in England and Wales. Appl Environ Microbiol 1996, 62: 3446-3452.Google Scholar
- Momotani E, Romona NM, Yoshihara K, Momotani Y, Hori M, Ozaki H, Eda S, Ikegami M: Molecular pathogenesis of bovine paratuberculosis and human inflammatory bowel diseases. Vet Immunol Immunopathol 2012, 148: 55-68. 10.1016/j.vetimm.2012.03.005View ArticleGoogle Scholar
- Neuman MG, Nanau RM: Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res 2012, 160: 29-44. 10.1016/j.trsl.2011.09.001View ArticleGoogle Scholar
- Neurath M, Fuss I, Strober W: TNBS-colitis. Int Rev Immunol 2000, 19: 51-62. 10.3109/08830180009048389View ArticleGoogle Scholar
- Nielsen SS, Toft N: A review of prevalences of paratuberculosis in farmed animals in Europe. Prev Vet Med 2009, 88: 1-14. 10.1016/j.prevetmed.2008.07.003View ArticleGoogle Scholar
- Olsen I, Tollefsen S, Aagaard C, Reitan LJ, Bannantine JP, Andersen P, Sollid LM, Lundin KE: Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients. PLoS One 2009, 4: e5641. 10.1371/journal.pone.0005641View ArticleGoogle Scholar
- Over K, Crandall PG, O'Bryan CA, Ricke SC: Current perspectives on Mycobacterium avium subsp. paratuberculosis , Johne's disease, and Crohn's disease: a review. Crit Rev Microbiol 2011, 37: 141-156. 10.3109/1040841X.2010.532480View ArticleGoogle Scholar
- Paccagnini D, Sieswerda L, Rosu V, Masala S, Pacifico A, Gazouli M, Ikonomopoulos J, Ahmed N, Zanetti S, Sechi LA: Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis , SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One 2009, 4: e7109. 10.1371/journal.pone.0007109View ArticleGoogle Scholar
- Patel A, Shah N: Mycobacterium avium subsp paratuberculosis -Incidences in milk and milk products, their isolation, enumeration, characterization, and role in human health. J Microbiol Immunol Infect 2011, 44: 473-479. 10.1016/j.jmii.2011.04.009View ArticleGoogle Scholar
- Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ: The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010, 105: 289-297. 10.1038/ajg.2009.579View ArticleGoogle Scholar
- Phavichitr N, Cameron DJ, Catto-Smith AG: Increasing incidence of Crohn's disease in Victorian children. J Gastroenterol Hepatol 2003, 18: 329-332. 10.1046/j.1440-1746.2003.02975.xView ArticleGoogle Scholar
- Pierce ES: Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathog 2009, 5: e1000234. 10.1371/journal.ppat.1000234View ArticleGoogle Scholar
- Raizman EA, Fetrow JP, Wells SJ: Loss of income from cows shedding Mycobacterium avium subspecies paratuberculosis prior to calving compared with cows not shedding the organism on two Minnesota dairy farms. J Dairy Sci 2009, 92: 4929-4936. 10.3168/jds.2009-2133View ArticleGoogle Scholar
- Romero C, Hamdi A, Valentine JF, Naser SA: Evaluation of surgical tissue from patients with Crohn's disease for the presence of Mycobacterium avium subspecies paratuberculosis DNA by in situ hybridization and nested polymerase chain reaction. Inflamm Bowel Dis 2005, 11: 116-125. 10.1097/00054725-200502000-00004View ArticleGoogle Scholar
- Sartor RB: Does Mycobacterium avium subspecies paratuberculosis cause Crohn's disease? Gut 2005, 54: 896-898. 10.1136/gut.2004.055889View ArticleGoogle Scholar
- Scanu AM, Bull TJ, Cannas S, Sanderson JD, Sechi LA, Dettori G, Zanetti S, Hermon-Taylor J: Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities. J Clin Microbiol 2007, 45: 3883-3890. 10.1128/JCM.01371-07View ArticleGoogle Scholar
- Simmons A: Crohn's disease: Genes, viruses and microbes. Nature 2010, 466: 699-700. 10.1038/466699aView ArticleGoogle Scholar
- Singh AV, Singh SV, Singh PK, Sohal JS: Is Mycobacterium avium subsp. paratuberculosis , the cause of Johne's disease in animals, a good candidate for Crohn's disease in man? Indian J Gastroenterol 2010, 29: 53-58. 10.1007/s12664-010-0019-yView ArticleGoogle Scholar
- Speer CA, Scott MC, Bannantine JP, Waters WR, Mori Y, Whitlock RH, Eda S: A novel enzyme-linked immunosorbent assay for diagnosis of Mycobacterium avium subsp. paratuberculosis infections (Johne's Disease) in cattle. Clin Vaccine Immunol 2006, 13: 535-540. 10.1128/CVI.13.5.535-540.2006View ArticleGoogle Scholar
- Stabel JR: Johne's disease and milk: do consumers need to worry? J Dairy Sci 2000, 83: 1659-1663. 10.3168/jds.S0022-0302(00)75034-XView ArticleGoogle Scholar
- Stabel JR, Lambertz A: Efficacy of pasteurization conditions for the inactivation of Mycobacterium avium subsp. paratuberculosis in milk. J Food Prot 2004, 67: 2719-2726.Google Scholar
- Stabel JR, Steadham EM, Bolin CA: Heat inactivation of Mycobacterium paratuberculosis in raw milk: are current pasteurization conditions effective? Appl Environ Microbiol 1997, 63: 4975-4977.Google Scholar
- Stabel JR, Palmer MV, Harris B, Plattner B, Hostetter J, Robbe-Austerman S: Pathogenesis of Mycobacterium avium subsp. paratuberculosis in neonatal calves after oral or intraperitoneal experimental infection. Vet Microbiol 2009, 136: 306-313. 10.1016/j.vetmic.2008.11.025View ArticleGoogle Scholar
- te Velde AA, Verstege MI, Hommes DW: Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 2006, 12: 995-999. 10.1097/01.mib.0000227817.54969.5eView ArticleGoogle Scholar
- Tsianos EV, Katsanos KH, Tsianos VE: Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol 2012, 18: 105-118. 10.3748/wjg.v18.i2.105View ArticleGoogle Scholar
- Tuci A, Tonon F, Castellani L, Sartini A, Roda G, Marocchi M, Caponi A, Munarini A, Rosati G, Ugolini G, Fuccio L, Scagliarini M, Bazzoli F, Belluzzi A: Fecal Detection of Mycobacterium avium Paratuberculosis Using the IS900 DNA Sequence in Crohn's Disease and Ulcerative Colitis Patients and Healthy Subjects. Dig Dis Sci 2011, 56: 2957-2962. 10.1007/s10620-011-1699-6View ArticleGoogle Scholar
- Umeno J, Asano K, Matsushita T, Matsumoto T, Kiyohara Y, Iida M, Nakamura Y, Kamatani N, Kubo M: Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2011, 17: 2407-2415. 10.1002/ibd.21651View ArticleGoogle Scholar
- Van Kruiningen HJ: Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans. Inflamm Bowel Dis 1999, 5: 183-191. 10.1097/00054725-199908000-00007View ArticleGoogle Scholar
- Veazey RS, Taylor HW, Horohov DW, Krahenbuhl JL, Oliver JL 3rd, Snider TG 3rd: Histopathology of C57BL/6 mice inoculated orally with Mycobacterium paratuberculosis . J Comp Pathol 1995, 113: 75-80. 10.1016/S0021-9975(05)80071-4View ArticleGoogle Scholar
- Vora P, Shih DQ, McGovern DP, Targan SR: Current concepts on the immunopathogenesis of inflammatory bowel disease. Front Biosci (Elite Ed) 2012, 4: 1451-1477.View ArticleGoogle Scholar
- Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE: Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989, 2: 1057-1062.View ArticleGoogle Scholar
- Wall S, Kunze ZM, Saboor S, Soufleri I, Seechurn P, Chiodini R, McFadden JJ: Identification of spheroplast-like agents isolated from tissues of patients with Crohn's disease and control tissues by polymerase chain reaction. J Clin Microbiol 1993, 31: 1241-1245.Google Scholar
- Watanabe Y, Watari E, Matsunaga I, Hiromatsu K, Dascher CC, Kawashima T, Norose Y, Shimizu K, Takahashi H, Yano I, Sugita M: BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components. Vaccine 2006, 24: 5700-5707. 10.1016/j.vaccine.2006.04.049View ArticleGoogle Scholar
- Wirtz S, Neufert C, Weigmann B, Neurath MF: Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007, 2: 541-546.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.